KR101002163B1 - 사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 - Google Patents
사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 Download PDFInfo
- Publication number
- KR101002163B1 KR101002163B1 KR1020090029923A KR20090029923A KR101002163B1 KR 101002163 B1 KR101002163 B1 KR 101002163B1 KR 1020090029923 A KR1020090029923 A KR 1020090029923A KR 20090029923 A KR20090029923 A KR 20090029923A KR 101002163 B1 KR101002163 B1 KR 101002163B1
- Authority
- KR
- South Korea
- Prior art keywords
- cypb
- cells
- disease
- cyclophilin
- stress
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (8)
- 사이클로필린 B의 서열번호 1 또는 서열번호 2로 표시되는 소포체 스트레스 반응영역(ERSE)을 포함하는, 글루타민다량체 유발 응집 질환, 심혈관질환, 고호모시스테인증 및 동맥경화증으로 이루어진 군에서 선택되는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물.
- 제1항에 있어서, 상기 소포체 스트레스 반응영역을 통해 발현이 활성화되는 사이클로필린 B는 PPIase 활성을 가지는 것을 특징으로 하는 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090029923A KR101002163B1 (ko) | 2009-04-07 | 2009-04-07 | 사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090029923A KR101002163B1 (ko) | 2009-04-07 | 2009-04-07 | 사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100111475A KR20100111475A (ko) | 2010-10-15 |
KR101002163B1 true KR101002163B1 (ko) | 2010-12-17 |
Family
ID=43131720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090029923A KR101002163B1 (ko) | 2009-04-07 | 2009-04-07 | 사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101002163B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20120030810A (ko) * | 2010-09-20 | 2012-03-29 | 경희대학교 산학협력단 | 사이클로필린 b를 포함하는 아밀로이드원성 질환 예방 및 치료용 조성물 |
WO2023087062A1 (en) * | 2021-11-18 | 2023-05-25 | Resonance Health Analysis Services Pty Ltd | Method for treating cyclophilin b associated diseases |
CN115372618A (zh) * | 2022-09-19 | 2022-11-22 | 首都医科大学附属北京胸科医院 | 一种检测蛋白标志物水平的试剂在制备用于评估肿瘤治疗效果的诊断产品中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040146892A1 (en) * | 1999-11-03 | 2004-07-29 | Mitokor, Inc. | Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
-
2009
- 2009-04-07 KR KR1020090029923A patent/KR101002163B1/ko active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040146892A1 (en) * | 1999-11-03 | 2004-07-29 | Mitokor, Inc. | Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
Also Published As
Publication number | Publication date |
---|---|
KR20100111475A (ko) | 2010-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ma et al. | Low-dose metformin targets the lysosomal AMPK pathway through PEN2 | |
Kim et al. | Overexpressed cyclophilin B suppresses apoptosis associated with ROS and Ca2+ homeostasis after ER stress | |
Shteinfer‐Kuzmine et al. | Selective induction of cancer cell death by VDAC 1‐based peptides and their potential use in cancer therapy | |
Li et al. | Paradoxical overexpression and translocation of connexin43 in homocysteine-treated endothelial cells | |
Han et al. | Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron | |
US8530392B2 (en) | Test agent for visceral obesity and use thereof | |
Beak et al. | The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure | |
Du et al. | A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis | |
Bidaux et al. | Targeting of short TRPM8 isoforms induces 4TM-TRPM8-dependent apoptosis in prostate cancer cells | |
Matafora et al. | Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity | |
US10695324B2 (en) | Treatment for wolfram syndrome and other endoplasmic reticulum stress disorders | |
US20230233517A1 (en) | Compositions and methods for preventing and treating radiation-induced bystander effects caused by radiation or radiotherapy | |
Lévy et al. | Ubiquitylation of a melanosomal protein by HECT-E3 ligases serves as sorting signal for lysosomal degradation | |
Arrington et al. | Targeting of the molecular chaperone oxygen-regulated protein 150 (ORP150) to mitochondria and its induction by cellular stress | |
KR101002163B1 (ko) | 사이클로필린 b를 포함하는 소포체 스트레스 관련 질환의 예방 및 치료용 조성물 | |
US11124779B2 (en) | Compositions and methods for treating and preventing pancreatitis, renal injury and cancer | |
US7846909B2 (en) | Method and compositions for inhibiting MAGE protein interaction with KAP-1 | |
CN113209303A (zh) | Wwp1通过溶酶体途径降解癌蛋白muc1抑制肿瘤及其应用 | |
US20120213801A1 (en) | Phosphorylated Twist1 and cancer | |
CN110812470A (zh) | 用于代谢调节的方法和组合物 | |
KR100880850B1 (ko) | 고형암 세포에서 사이클로필린 a의 발현을 억제하는물질을 포함하는 시스플라틴에 대한 내성 억제용 약제학적조성물 및 그를 이용하여 고형암의 시스플라틴에 대한내성을 억제하는 방법 | |
US20200149049A1 (en) | Methods and compositions relating to anti-calcification | |
US20130157959A1 (en) | Use of hades as tumor suppressor target | |
US20110190218A1 (en) | Bag-1 peptide that inhibits prostate cancer | |
US20100113557A1 (en) | Method for prevention of tumor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130628 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140627 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150623 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161207 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20171201 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181203 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20191202 Year of fee payment: 10 |